Investigation of anticancer potencies of newly generated Schiff base imidazolylphenylheterocyclic-2-ylmethylenethiazole-2-amines

Multi-heterocyclic anticancer drug-like molecules are designed, synthesized and studied against different cancer cell line as well as a non-cancer cell line.